Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients

Journal of Surgical Oncology

Volumn 87, Issue 4, 2004, Pages 182-186

  Koike, Hiroshi ^a   Ichikawa, Daisuke ^a   Ikoma, Hisashi ^a   Otsuji, Eigo ^a   Kitamura, Kazuya ^a   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Carcinoembryonic antigen mRNA; E cadherin; Gastric cancer; p16; Retinoic acid receptor beta (RAR )

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; PROTEIN P16; RETINOIC ACID RECEPTOR BETA; UVOMORULIN;

ABERRANT METHYLATION; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER INVASION; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DNA HYPERMETHYLATION; DNA METHYLATION; EARLY DIAGNOSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; PATIENT SELECTION; POLYMERASE CHAIN REACTION; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; VEIN INVASION;

ADENOCARCINOMA; AGED; CADHERINS; CARCINOEMBRYONIC ANTIGEN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 4444357058     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20106     Document Type: Article

References (27)

1. Pisani PDM, Bray F, Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29.
2. Maruyama K, Okabayashi K, Kinoshita Y: Prognosis in gastric cancer in Japan and its limits of radicality. World J Surg 1991;11:418.
3. Kitamura K, Ymaguchi T, Taniguchi T, et al.: Clinicopathological characteristics of gastric cancer in the elderly. Br J Cancer 1996;73:798-802.
4. Ishigami S, Natsugoe S, Hokita S, et al.: Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 2001;32:41-44.
5. Pectasides D, Mylonakis A, Kostopoulou M, et al.: CEA, CA19-9, and CA-50 in monitoring gastric carcinoma. Am J Clin Oncol 1997;20:348-353.
6. Marrelli D, Pinto E, De Stefano A, et al.: Clinical utility of CEA, CA19-9, and CA72-4 in the follow-up patients with respectable gastric cancer. Am J Surg 2001;181:16-19.
7. Gerhard M, Juhl H, Kothoff H: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994;12:725-729.
8. Soeth E, Vogel I, Roder C, et al.: Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997;57:3106-3110.
9. Mori M, Mimori K, Ueo H, et al.: Molecular detection of circulating solid carcinoma cells in the peripheral blood: The concept of early systemic disease. Int J Cancer 1996;68:739-743.
10. Nishida S, Kitamura K, Ichikawa D, et al.: Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer. Anticancer Res 2000;20:2155-2159.
11. Wu CW, Lin YY, Chen GD, et al.: Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade. Br J Cancer 1999;80:483-488.
12. Maehara Y, Kakeji Y, Watanabe A, et al.: Clinical implications of serum anti-p53 antibodies for patients with gastric carcinoma. Cancer 1999;15:85:302-308.
13. Sorenson GD: Detection of mutated K-ras sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer. Clin Cancer Res 2000;6:2129-2137.
14. Mulcahy H, Lyautey J, Lederrey C, et al.: A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res 1998;4:271-275.
15. Yamada T, Nakamori S, Ohzato H, et al.: Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinomas: Correlation with clinicopathological features. Clin Cancer Res 1998;4:1527-1532.
16. Herman JG, Graff JR, Myohanen S, et al.: Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-9826.
17. Silva JM, Dominguez G, Garcia JM, et al.: Presence of tumor DNA in plasma of breast cancer patients: Clinicopathological correlations. Cancer Res 1999;59:67-70.
18. Lee TL, Leung WK, Chan MWY, et al.: Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric cancer. Clin Cancer Res 2002;8:1761-1766.
19. Sanchez-Cespedes M, Esteller M, Wu L, et al.: Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 2000;60:892-895.
20. Wong IH, Lo YM, Zhang J, et al.: Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Clin Cancer Res 2000;6:3516-3521.
21. Hibi K, Taguchi M, Nakayama H, et al.: Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 2001;7:3135-3138.
22. Japanese Gastric Cancer Association, Japanese classification of gastric carcinoma: 2nd English edn. Gastric Cancer 1998;1:10-24.
23. Kuroki T, Trapasso F, Yendamuri S, et al.: Allele loss and promoter hypermethylation of VHL, RARβ, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal cancer. Cancer Res 2003;63:3724-3728.
24. Leon SA, Shapiro B, Sklaroff DM, et al.: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1997;37:646-650.
25. Oue N, Motoshita J, Yokozaki H, et al.: Distinct promoter hypermethylation of p16, CDH1 and RARβ in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinoma. J Pathol 2002;198:55-59.
26. Yamaguchi K, Takagi Y, Aoki S, et al.: Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000;232:58-65.
27. Taniguchi T, Makino M, Suzuki K, et al.: Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. Cancer 2000;89:971-976.